抗CXCL10抗体(Anti-CXCL10, Mouse, Goat-Poly, Biotin antibody)

掲載日情報:2021/01/28 現在Webページ番号:27692

CXCL10に対する抗体(Anti-CXCL10, Mouse, Goat-Poly, Biotin )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-CXCL10, Mouse, Goat-Poly, Biotin <Anti-CRG-2> <Anti-IP-10>
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 15
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Mouse CXCL10/IP-10/CRG-2 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB466-500,スタンダードとして#466-CR-010を用いる。
別名:C7
Genbank No: 3627
Protein Accession No: Q548V9
法規制等
保存条件 -20℃ 法規備考
抗原種 Mouse 免疫動物 Goat クラス IgG 標識 Biotin
交差性 Mouse 適用 ELISA,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事 免疫染色システム ImmPRESS® Reagent Anti-Goat IgG
M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-CXCL10, Mouse, Goat-Poly, Biotin <Anti-CRG-2> <Anti-IP-10>

文献数: 15

説明文 マッチドペア:Mouse CXCL10/IP-10/CRG-2 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB466-500,スタンダードとして#466-CR-010を用いる。
別名:C7
Genbank No: 3627
Protein Accession No: Q548V9
法規制等
保存条件 -20℃ 法規備考
抗原種 Mouse 免疫動物 Goat
交差性 Mouse 適用 ELISA,Western Blot
標識 Biotin 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事 免疫染色システム ImmPRESS® Reagent Anti-Goat IgG
M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityMouse
LabelBiotin
ImmunogenE. coli-derived recombinant mouse CXCL10/IP‑10/CRG‑2 (R&D Systems, Catalog # 466-CR)Ile22-Pro98Accession # Q548V9
SourcePolyclonal Goat IgG
PurificationAntigen Affinity-purified
SpecificityDetects mouse CXCL10/IP‑10/CRG‑2 in ELISAs and Western blots. In sandwich immunoassays, less than 0.5% cross-reactivity with recombinant human IP‑10, recombinant mouse (rm) PF4, rmMIG, rmLIX, and rmI-TAC is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot0.1 µg/mLRecombinant Mouse CXCL10/IP‑10/CRG‑2 (Catalog # 466-CR)
Mouse CXCL10/IP-10/CRG-2 Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Mouse CXCL10/IP‑10/CRG‑2 Antibody (Catalog #MAB466 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Mouse CXCL10/IP‑10/CRG‑2 Biotinylated Antibody (Catalog #BAF466 )
ELISA Standard  Recombinant Mouse CXCL10/IP-10/CRG-2 Protein (Catalog #466-CR )
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.

目次に戻る

Related Product & Information

BackgroundCXCL10/IP-10/CRG-2
background_contentBackground:
CXCL10/IP-10/CRG-2
The gene for CRG-2, a mouse homolog of human IP-10, was originally identified as an immediate early gene induced in response to macrophage activation. It has been shown that CRG-2 mRNA is induced by alpha / beta / gamma -interferons and by lipopolysaccharide in macrophages, astrocytes and microglia. Human IP-10 was also shown to be expressed in activated T-lymphocytes, splenocytes, keratinocytes, osteoblasts, astrocytes, and smooth muscle cells. Mouse CRG-2 cDNA encodes a 98 amino acid (aa) residue precursor protein with a 21 aa residue signal peptide that is cleaved to form the 77 aa residue secreted mature protein. Mature CRG-2 shares approximately 67% amino acid sequence identity with human IP-10. The amino acid sequence of CRG-2 identified the protein as a member of the chemokine alpha subfamily that lacks the ELR domain. CRG-2 has been shown to be a chemoattractant for activated T-lymphocytes. Human IP-10 has also been reported to be a potent inhibitor of angiogenesis and to display a potent thymus-dependent anti-tumor effect. A chemokine receptor specific for IP-10 and MIG (CXCR3) has been cloned and shown to be highly expressed in IL-2-activated T-lymphocytes.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D
    Authors: K Motani, H Kosako
    J. Biol. Chem., 2018;0(0):.
    Species: Mouse
    Sample Type: Cell Lysates
    Application: WB

  2. IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3
    Authors: R Lv, J Zhao, M Lei, D Xiao, Y Yu, J Xie
    Cell. Physiol. Biochem., 2017;42(5):1961-1972.
    Species: Mouse
    Sample Type: Serum
    Application: ELISA detection

  3. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
    Authors: Barreira da Silva R, Laird M, Yatim N, Fiette L, Ingersoll M, Albert M
    Nat Immunol, 2015;16(8):850-8.

  4. Monocyte- and Neutrophil-Derived CXCL10 Impairs Efficient Control of Blood-Stage Malaria Infection and Promotes Severe Disease.
    Authors: Ioannidis L, Nie C, Ly A, Ryg-Cornejo V, Chiu C, Hansen D
    J Immunol, 2015;196(3):1227-38.
    Species: Mouse
    Sample Type: Tissue Homogenates
    Application: ELISA detection

  5. Colonic patch and colonic SILT development are independent and differentially regulated events.
    Authors: Baptista A, Olivier B, Goverse G, Greuter M, Knippenberg M, Kusser K, Domingues R, Veiga-Fernandes H, Luster A, Lugering A, Randall T, Cupedo T, Mebius R
    Mucosal Immunol, 2013;6(3):511-21.
    Species: Mouse
    Sample Type: Whole Tissue
    Application: IF

  6. Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.
    Authors: Leconet W, Petit P, Peraldi-Roux S, Bresson D
    Mol Ther, 2012;20(12):2315-25.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Flow

  7. Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
    Authors: Meng Y, Efimova EV, Hamzeh KW
    Mol. Ther., 2012;20(5):1046-55.
    Species: Mouse
    Sample Type: Whole Tissue
    Application: IHC Paraffin-embedded

  8. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
    Authors: Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, Nakayama T, Yoshie O, Nose M, Yasukawa M
    Arthritis Rheum., 2006;54(4):1174-83.
    Species: Mouse
    Sample Type: Whole Tissue
    Application: IHC Paraffin-embedded

  9. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).
    Authors: Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A, Sica A
    Blood, 2005;107(5):2112-22.
    Species: Mouse
    Sample Type: Whole Tissue
    Application: IHC



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。